DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Kowalski K, Nielsen J, Roy A. , et al.
Apixaban exposure and anti-Xa activity in nonvalvular atrial fibrillation patients: an application of population PK/PD analysis.
J Pharmacokinet Pharmacodyn 2014;
41 (Suppl. 01) 7-101
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.